Pharma Commercial AI Operating Model™

Redesigning the Pharma Commercial Operating Model for the AI Era

Helping pharmaceutical commercial organizations transform how marketing, commercial operations, medical, technology, data, and agency teams work together — combining AI, Veeva, enterprise data, and modern operating models to accelerate commercial execution.

The model

The Pharma Commercial AI Operating Model™

Instead of implementing isolated AI tools, we redesign how commercial work is executed — aligning strategy, governance, people, process, technology, data, and AI into one governed system.

Pharma Commercial AI Operating Model™

Redesign the work before scaling the workers.

Align strategy, governance, people, process, technology, data, and AI into one governed commercial system. Select a dimension to explore it.

Nashiah flagshipPharma Commercial AI Operating Model
Commercial strategyAnchor AI investment to measurable business outcomes.
Executive prioritiesUse-case portfolioValue metricsRoadmap

Problems we solve

AI has been adopted. Work has not changed.

Most organizations already have ChatGPT, Copilot, Claude, or other AI tools. The challenge isn't access to AI — it's redesigning how commercial work gets done.

Your commercial process has too many handoffs

AI does not fix a fragmented workflow by itself — it usually makes the wrong process run faster.

We redesign the workflow first — mapping tasks, ownership, approvals, and dependencies — then deploy AI workers into the new process to cut handoffs and cycle time.

How we solve it

AI adoption is moving faster than your controls

Many teams are already using AI, but far fewer have the SOPs, audits, and guardrails needed to scale it safely.

We establish the governance model before workers go live: policies, approved use cases, review checkpoints, logging, escalation, and audit-ready controls.

How we solve it

Compliance and MLR come in too late

If review happens only after content is finished, AI creates more late-stage rework instead of more speed.

We move compliance earlier by grounding content in approved claims, references, and brand rules before formal review begins.

How we solve it

Your approved knowledge is too hard to find

Teams lose time searching across labels, decks, claims, and vaults instead of reusing what is already approved.

We build a governed knowledge layer that makes approved content searchable, traceable, and reusable across medical, brand, and commercial teams.

How we solve it

Your assistants cannot act across disconnected systems

AI workers fail when Veeva, CRM, DAM, analytics, and collaboration tools remain isolated.

We connect the systems behind the workflow so AI workers can retrieve context, route work, and support end-to-end execution.

How we solve it

You cannot treat AI output as regulator-ready

In regulated work, assistants need proof, provenance, and safe refusal — not just fluent answers.

We implement verified workflows with citations, confidence policies, and human approval before any consequential use.

How we solve it

Your content engine is not learning from results

If AI only drafts content but never learns from channel performance, it stays tactical.

We connect content, audience, and campaign telemetry so the organization can optimize messaging, reuse what works, and demonstrate ROI.

How we solve it

Your pilots never become an operating platform

One-off assistants rarely become enterprise capability without a common platform and reusable architecture.

We turn pilots into a repeatable platform with shared governance, integrations, worker patterns, and operating metrics.

How we solve it

The transformation

From fragmented execution to connected intelligence

Drag the divider to compare the operating model most pharma teams have today with the connected commercial system Nashiah enables.

Before Nashiah

Tools everywhere. Evidence nowhere.

Data, content, reporting, field insight, and MLR workflows remain disconnected — slowing decisions and increasing risk.

With Nashiah

One connected commercial evidence loop.

Data, content, platforms, and AI agents work together to explain what changed, why it changed, and what to do next.

Connected
Fragmented

How we deliver

The Nashiah Transformation Framework

A connected path from commercial vision to continuous operations — each stage a prerequisite for responsible AI scale. Select a stage to explore it.

Nashiah transformation framework

A connected path from vision to continuous operations.

Each stage establishes a prerequisite for responsible AI scale. Select a stage to explore it.

Stage 1 · Commercial visionCreate a shared executive definition of value and success.
North StarAlignmentBusiness metricsInvestment thesis

Our North Star · Veeva AI Enablement

Operationalizing AI across the Veeva ecosystem

Veeva is the foundation of modern pharmaceutical commercial operations — and our most capable offering. We help organizations prepare for, integrate, operationalize, and continuously optimize AI across Veeva-centered environments.

Who we serve

Industries

Pharmaceutical Manufacturers
Pharma Commercial Organizations
Pharma Marketing Agencies
Biotechnology
Medical Device
Healthcare

Why Nashiah

Built specifically for pharma commercial

Built specifically for pharma commercial

We understand commercial operations, brand teams, omnichannel marketing, Veeva platforms, MLR workflows, and the technology required to support regulated execution.

Technology depth

Deep enterprise delivery experience across cloud, AI, cybersecurity, application development, DevOps, and managed services in regulated industries.

From strategy to operations

We don't stop at recommendations. We help organizations design, build, integrate, operate, and continuously improve their commercial operating model.

AI with governance

AI adoption requires governance before automation. We help establish the policies, operating models, and controls required for responsible enterprise AI.

Where are you today?

A practical path from pilots to continuous intelligence

Find the next operating-model capability required for responsible scale. Select a stage to explore it.

Pharma AI maturity

Move from isolated pilots to continuous intelligence.

Use the maturity curve to identify the next operating-model capability required for responsible scale.

Stage 1 · ExperimentCreate a governed path from promising pilots to enterprise value.
Use-case inventoryRisk reviewPilot metricsProduction roadmap

Executive assessments

Practical entry points for leaders evaluating readiness

Short, structured assessments that turn a broad AI ambition into a prioritized, board-ready plan.

Commercial Operating Model Assessment

Evaluate workflow, handoffs, decision rights, and readiness to scale AI across commercial execution.

Request this assessment

AI Readiness Assessment

Benchmark your use cases, governance, data, and adoption against a path to production-grade AI.

Request this assessment

Veeva AI Assessment

Assess adoption and architecture across Veeva AI, Nitro, Vault, CRM, and Data Cloud.

Request this assessment

Commercial Data Assessment

Review data connectivity, quality, semantics, and AI-readiness across commercial systems.

Request this assessment

Content Supply Chain Assessment

Map planning, creation, MLR review, reuse, and omnichannel adaptation to find the bottlenecks.

Request this assessment

AI Governance Assessment

Check policies, autonomy boundaries, human oversight, logging, and audit-readiness for responsible AI.

Request this assessment

Trusted by leading healthcare, life sciences & enterprise organizations

ATG
Teva
Cordavis
CVS Health
Emalex Biosciences
City of Hope
HealthFitness
Caterpillar
Medical Solutions
HEALTHeLINK
Trustmark
CNH Industrial

Your operating model determines your AI success

Organizations that simply deploy AI tools improve individual productivity. Organizations that redesign their commercial operating model transform how work gets done. Nashiah helps you build the operating model required to scale AI across strategy, content, Veeva, data, analytics, and commercial execution.